Resmetirom Tablet Franchise in Ahmedabad

Lipid & Liver Care Tablet Supplier in Mumbai

NAFLD Medicine Distributor in Delhi

Metabolic Health Pharma Franchise in Bangalore

Resmetirom Tablet Stockist in Hyderabad
Lipid & Liver Care Tablet Manufacturer & Exporter in Chandigarh

Home/Products /resmetirom-60mg-tablet

Restripe 60 Tablet

Composition : Resmetirom (60mg) Tablet

Dosage Form : Tablet

Packaging Type : in a Bottle

Packaging : 30 Tablets

Price : ₹0/-

Please Contact For Best Price

Restripe 60 Tablet contains Resmetirom 60mg, a targeted therapy for lipid and liver health management. It helps reduce liver fat accumulation and improve lipid metabolism, supporting patients with non-alcoholic fatty liver disease (NAFLD) and other metabolic liver disorders.

This tablet is gaining attention among prescribers due to its novel mechanism and efficacy, providing noticeable improvements in liver function and metabolic markers. Patients benefit from better liver health, improved cholesterol profiles, and enhanced long-term wellness.

For franchise partners, Restripe 60 Tablet is a high-demand product in the cardio-metabolic and liver care segment, offering strong market potential. Its advanced clinical relevance ensures repeat prescriptions and prescriber trust, making it a profitable addition to specialty portfolios.

With growing awareness of liver health and metabolic disorders, Restripe 60 Tablet provides sustainable sales opportunities, helping partners establish a strong presence in the lipid and liver care segment while expanding business reach.

Read More

About the Product

Restripe 60 Tablet contains Resmetirom 60mg, a targeted therapy for lipid and liver health management. It helps reduce liver fat accumulation and improve lipid metabolism, supporting patients with non-alcoholic fatty liver disease (NAFLD) and other metabolic liver disorders.

This tablet is gaining attention among prescribers due to its novel mechanism and efficacy, providing noticeable improvements in liver function and metabolic markers. Patients benefit from better liver health, improved cholesterol profiles, and enhanced long-term wellness.

For franchise partners, Restripe 60 Tablet is a high-demand product in the cardio-metabolic and liver care segment, offering strong market potential. Its advanced clinical relevance ensures repeat prescriptions and prescriber trust, making it a profitable addition to specialty portfolios.

With growing awareness of liver health and metabolic disorders, Restripe 60 Tablet provides sustainable sales opportunities, helping partners establish a strong presence in the lipid and liver care segment while expanding business reach.

Common side effects may include mild headache, fatigue, nausea, diarrhea, or transient changes in liver enzyme levels. Some patients may experience palpitations or insomnia. Any severe, persistent, or unusual symptoms should be reported immediately to a healthcare professional.

Restripe 60 Tablet is indicated for the treatment of non-alcoholic steatohepatitis (NASH) and associated dyslipidemia in adults. It is used to reduce hepatic fat content, improve lipid metabolism, and support liver function in patients at risk of progressive liver disease.

Restripe 60 Tablet should be taken as prescribed and not used in patients with severe liver dysfunction or hypersensitivity to Resmetirom. Regular monitoring of liver function tests and lipid profile is recommended during therapy. Inform your doctor about other medications or underlying health conditions before starting treatment.

Store Restripe 60 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children and do not use beyond the expiry date indicated on the pack.

Get in Touch